Marie-Soleil Gauthier1, Rémi Rabasa-Lhoret, Denis Prud'homme, Antony D Karelis, Dawei Geng, Bert van Bavel, Jérôme Ruzzin. 1. Institut de Recherches Cliniques de Montréal (M.-S.G., R.R.-L.), Montréal, Québec, H2W 1R7, Canada; Montreal Diabetes Research Centre at the Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) (M.-S.G., R.R.-L.) Montréal, Québec, H1W 4A4, Canada; The Nutrition Department (R.R.-L.), Université de Montréal; the Endocrinology Division (R.R.-L.), Montreal University Hospital, Montréal, Québec, Canada H2W 1T8; School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada; Institut de Recherche de l'Hôpital Montfort (D.P.), Ottawa, Ontario, K1K 0T2, Canada; Department of Kinanthropology (A.K.), Université du Québec à Montréal, Montréal, Québec, Canada H3C 3P8; MTM Research Center (D.G., B.v.B.), School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden; and Department of Biology (J.R.), University of Bergen, N-5006 Bergen, Norway.
Abstract
CONTEXT: Although obesity is strongly linked to insulin resistance and type 2 diabetes, a subset of obese individuals termed metabolically healthy but obese (MHO) appears relatively protected from the development of cardiometabolic complications. The origins of this metabolically healthy phenotype remain unclear. Recently, persistent organic pollutants (POPs) have emerged as potential endocrine disruptors. OBJECTIVE: The aim of this study was to test the hypothesis that the MHO phenotype presents lower circulating levels of POPs as compared to the metabolically abnormal obese (MAO) phenotype. DESIGN, SETTING, AND PATIENTS: We conducted a cross-sectional study of 76 nondiabetic obese (body mass index ≥30 kg/m(2)) postmenopausal women. MAIN OUTCOME MEASURES: Plasma concentrations of 21 POPs as well as cardiometabolic risk factors were analyzed. RESULTS: For similar age, body mass index, and fat mass index, MHO women (n = 40) showed higher insulin sensitivity levels and a more favorable cardiometabolic profile than MAO women (n = 36), as evidenced by a 2-fold increase in glucose disposal rates measured by the hyperinsulinemic-euglycemic clamp (P = .001). Among 18 detectable pollutants measured, MAO women had higher plasma concentrations of 12 POPs (fold increase, 1.4-2.9; P < .001-.036). Logistic regression analyses showed that the prevalence of the MAO phenotype was significantly associated with higher levels of total dioxin- and non-dioxin-like polychlorinated biphenyls (odds ratio, 4.7; 95% confidence interval, 1.8-12.5; P = .002), as well as trans-nonachlor (odds ratio, 6.1; 95% CI, 2.2-16.4; P < .001). CONCLUSION: Our study demonstrates that the metabolically healthy and abnormal phenotypes have distinct plasma POP profiles.
CONTEXT: Although obesity is strongly linked to insulin resistance and type 2 diabetes, a subset of obese individuals termed metabolically healthy but obese (MHO) appears relatively protected from the development of cardiometabolic complications. The origins of this metabolically healthy phenotype remain unclear. Recently, persistent organic pollutants (POPs) have emerged as potential endocrine disruptors. OBJECTIVE: The aim of this study was to test the hypothesis that the MHO phenotype presents lower circulating levels of POPs as compared to the metabolically abnormal obese (MAO) phenotype. DESIGN, SETTING, AND PATIENTS: We conducted a cross-sectional study of 76 nondiabetic obese (body mass index ≥30 kg/m(2)) postmenopausal women. MAIN OUTCOME MEASURES: Plasma concentrations of 21 POPs as well as cardiometabolic risk factors were analyzed. RESULTS: For similar age, body mass index, and fat mass index, MHO women (n = 40) showed higher insulin sensitivity levels and a more favorable cardiometabolic profile than MAOwomen (n = 36), as evidenced by a 2-fold increase in glucose disposal rates measured by the hyperinsulinemic-euglycemic clamp (P = .001). Among 18 detectable pollutants measured, MAOwomen had higher plasma concentrations of 12 POPs (fold increase, 1.4-2.9; P < .001-.036). Logistic regression analyses showed that the prevalence of the MAO phenotype was significantly associated with higher levels of total dioxin- and non-dioxin-like polychlorinated biphenyls (odds ratio, 4.7; 95% confidence interval, 1.8-12.5; P = .002), as well as trans-nonachlor (odds ratio, 6.1; 95% CI, 2.2-16.4; P < .001). CONCLUSION: Our study demonstrates that the metabolically healthy and abnormal phenotypes have distinct plasma POP profiles.
Authors: Gopi S Gadupudi; William D Klaren; Alicia K Olivier; Aloysius J Klingelhutz; Larry W Robertson Journal: Toxicol Sci Date: 2015-09-22 Impact factor: 4.849
Authors: Marie-Soleil Gauthier; Joelle R Pérusse; Marie-Ève Lavoie; Robert Sladek; S R Murthy Madiraju; Neil B Ruderman; Benoit Coulombe; Marc Prentki; Rémi Rabasa-Lhoret Journal: J Clin Endocrinol Metab Date: 2014-12 Impact factor: 5.958
Authors: Jeanett L Tang-Péronard; Berit L Heitmann; Tina K Jensen; Anne M Vinggaard; Sten Madsbad; Ulrike Steuerwald; Philippe Grandjean; Pál Weihe; Flemming Nielsen; Helle R Andersen Journal: Environ Res Date: 2015-07-30 Impact factor: 6.498
Authors: Gopi S Gadupudi; Benjamin A Elser; Fabian A Sandgruber; Xueshu Li; Katherine N Gibson-Corley; Larry W Robertson Journal: Toxicol Sci Date: 2018-06-01 Impact factor: 4.849